PROCEPT BioRobotics Corp.
(NASDAQ : PRCT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 2.46%606.651.0%$766.54m
DHRDanaher Corp. 2.21%315.300.7%$682.49m
ABTAbbott Laboratories 3.55%123.570.8%$641.18m
MDTMedtronic Plc -0.22%121.930.6%$532.83m
ISRGIntuitive Surgical, Inc. 1.18%340.270.8%$386.56m
ALGNAlign Technology, Inc. 2.15%607.066.3%$332.25m
BDXBecton, Dickinson & Co. 1.92%247.391.0%$316.50m
DXCMDexCom, Inc. 1.29%557.157.8%$288.98m
SYKStryker Corp. 0.99%273.541.3%$272.99m
EWEdwards Lifesciences Corp. 0.64%115.740.4%$261.28m
BSXBoston Scientific Corp. 0.53%44.371.0%$257.07m
IDXXIDEXX Laboratories, Inc. 0.57%644.633.8%$245.39m
AAgilent Technologies, Inc. 1.55%158.031.6%$219.68m
BAXBaxter International, Inc. 1.88%81.181.8%$193.42m
INMDInMode Ltd. -1.17%83.780.0%$176.38m

Company Profile

PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in Redwood City, CA.